Meanwhile, the half-lives of pre-ASS1 and mature mRNAs in glioma cells overexpressing METTL14 were significantly reduced, which indicated that METTL14 could promote the splicing of precursor mRNA and the degradation of ASS1 mature mRNA. The gene discussed is METTL14; the disease is central nervous system cancer.